Jun 19, 2020

Ausbiz interviews Starpharma CEO Dr Jackie Fairley

Ausbiz interviews Starpharma CEO Dr Jackie Fairley

Finance and market news website AusBiz interviewed Starpharma CEO Dr Jackie Fairley to discuss the company’s first radiotherapeutic candidate, DEP® lutetium. The candidate showed highly statistically significant anticancer activity, tumour regression and 100% survival in a human prostate cancer model. The interview also covered the company’s latest VivaGel® BV launch in Central and Eastern Europe.

To watch the full interview click here.

 

 This contains certain forward-looking statements.